Clinical Trial Update: RAD001, Cisplatin and Concurrent Radiation for Locally Advanced, Inoperable Head and Neck Cancer [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating RAD001 with cisplatin and concurrent radiation for locally advanced, inoperable head and neck cancer; study terminated with results pos…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Cancer

Drugs mentioned

• CISPLATIN (cisplatin)
• RAD001 (everolimus)

Snippet

Sponsor: howard safran | Conditions: Head and Neck Cancer | Phase 1 | Status: TERMINATED | Results posted: 2015-08-04